Core Viewpoint - The article highlights the increasing complexity and prevalence of financial fraud in listed companies, particularly focusing on the role of third parties in facilitating these fraudulent activities [2][4][18]. Group 1: Overview of Financial Fraud - The annual "5.15 National Investor Protection Day" serves as a reminder of the severe consequences of financial fraud, exemplified by the Zijing Storage case, which affected 17,000 investors and involved compensation of 1.086 billion yuan from four intermediary institutions [2]. - Since 2020, over 60% of administrative penalties by the China Securities Regulatory Commission (CSRC) for income fraud have involved transaction fraud, with more than 600 third-party entities implicated in 58 cases of transaction fraud [4][6]. Group 2: Evolution of Fraud Techniques - Financial fraud has evolved from simple accounting manipulations to systemic fraud that encompasses entire business processes, as seen in cases like Gome Communications and Oriental Group [5][10]. - Transaction fraud is characterized by the fabrication of non-existent transactions and manipulation of transaction processes, posing a more direct threat to market trust compared to traditional accounting manipulations [6][10]. Group 3: Role of Third Parties - Third parties, including customers, suppliers, and shell companies, play a crucial role in orchestrating financial fraud, with an average of over 10 third parties involved in each fraudulent case [11][12]. - The involvement of third parties often includes hidden relationships and the creation of complex transaction structures to obscure fraudulent activities, as demonstrated in various cases [12][13][14]. Group 4: Legal and Regulatory Challenges - Despite the high-pressure stance of the CSRC against financial fraud, third parties often escape significant legal repercussions, leading to a lack of accountability in the broader fraud ecosystem [18][19]. - The current legal framework does not adequately address the roles of third parties in financial fraud, resulting in a cycle of low risk and high reward for those involved in fraudulent activities [23]. Group 5: Recommendations for Improvement - There is an urgent need to enhance legal regulations and establish a comprehensive accountability mechanism for all parties involved in financial fraud, including third parties [23].

Group 1 - The core issue involves Langyuan Co., Ltd. being penalized by the China Securities Regulatory Commission for financial misconduct, specifically for inflating revenue, costs, and profits through fictitious contracts in 2019 [1] - The inflated figures included an increase in revenue by 52.51 million yuan, costs by 34.94 million yuan, and total profit by 18.17 million yuan, representing 9.03%, 7.94%, and 43.02% of the respective reported figures [1] - A subsequent correction announcement in September 2020 still reflected inflated figures, with adjusted revenue, costs, and profits remaining overstated by 37.88 million yuan, 27.23 million yuan, and 11.25 million yuan, which accounted for 6.68%, 6.17%, and 26.91% of the respective reported figures [1] Group 2 - On the same day the administrative penalty was announced, a board member of Langyuan submitted a resignation letter, stepping down from his positions as director, vice chairman, and member of the remuneration and assessment committee [2] - A lawsuit has been initiated regarding the false statements made by Langyuan, with ongoing proceedings aimed at compensating affected shareholders [3] - Shareholders who purchased shares between April 25, 2018, and April 25, 2023, or between April 30, 2020, and September 12, 2024, may be eligible to file for compensation [3]

证券代码：300175 证券简称：ST朗源 公告编号：2025-044 朗源股份有限公司 关于参加2025年山东辖区上市公司投资者 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路 演 APP，参与本次互动交流。活动时间为 2025 年 5 月 15 日（周四）15：00-16： 30。 届时公司财务总监王涛先生、董事会秘书李春丽女士、证券事务代表张雨婷 女士将在线就公司 2024 年度业绩、公司治理、发展战略、经营状况等投资者关 心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告！ 朗源股份有限公司董事会 二〇二五年五月十三日 网上集体接待日活动的公告 （本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。） 为进一步加强与投资者的互动交流，朗源股份有限公司（以下简称"公司"） 将参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的 "2025 年山东辖区上市公司投资者网上集体接待日活动"，现将相关事项公告 如下： ...

Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]

证券代码：300175 证券简称：ST 朗源 公告编号：2025-043 朗源股份有限公司 关于投资者诉讼事项的公告 （本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。） 重点内容提示： 1、案件所处的诉讼阶段：法院已受理，尚未开庭。 原告：6 名自然人投资者 被告：朗源股份有限公司等主体 （二）诉讼请求 2、上市公司所处的当事人地位：被告 3、涉案的金额：合计约为 39.80 万元。 4、对上市公司损益产生的影响：鉴于案件尚未开庭审理，目前无法判断对 公司本期利润或期后利润的影响。 一、本次诉讼受理的基本情况 朗源股份有限公司（以下简称"公司"）于近日收到青岛市中级人民法院发 来的《民事起诉状》。根据上述材料显示，青岛市中级人民法院已受理 6 名自然 人投资者诉公司证券虚假陈述责任纠纷一案，起诉金额合计约为 39.80 万元。 二、有关本案的基本情况 （一）诉讼各方当事人 1、判令被告赔偿原告投资损失人民币约为 39.80 万元。 2、本案诉讼费由被告承担。 （三）诉讼的主要事实与理由 2025 年 3 月，公司收到中国证监会山东监管局下发的《行政处罚事先告知 ...

Group 1: Financial Performance - The company reported a loss in 2024 primarily due to losses in the service sector [2] - The total revenue from the core business of agricultural products processing in 2024 was CNY 245 million [3] - The company will not distribute profits for 2024 due to losses and negative retained earnings [6] Group 2: Research and Development - The R&D investment for 2024 was CNY 0, with a possibility of increasing investment in the future to drive product innovation [2] Group 3: Future Goals and Strategies - The company aims to deepen market penetration and explore food business transformation [2] - The overseas sales accounted for 56.71% of total revenue in 2024, with plans to further expand this market share [7] - The company has a credit line of CNY 1.5 billion, which will be applied based on operational needs [5] Group 4: Cost Control and Efficiency - The company plans to adjust procurement strategies to lower raw material costs and optimize production processes [7]

Core Viewpoint - Langyuan Co., Ltd. has been penalized for financial fraud, facing a fine of 5 million yuan, while its former chairman received a 2 million yuan fine and a 5-year market ban, amidst ongoing financial struggles and a potential turnaround with new controlling shareholder, Dongfang Xingzhi [1][3][7] Financial Fraud Penalty - The China Securities Regulatory Commission (CSRC) found that Langyuan Co. inflated its 2019 revenue, costs, and profits by 52.51 million yuan, 34.94 million yuan, and 18.16 million yuan respectively, which constituted 9.03%, 7.94%, and 43.02% of the reported figures [2] - In a subsequent correction, the company still reported inflated figures of 37.88 million yuan, 27.23 million yuan, and 11.25 million yuan, representing 6.68%, 6.17%, and 26.91% of the respective totals [2][3] - The CSRC issued a warning and fines to several executives, including a 10-year market ban for the former general manager and a 5-year ban for the former chairman [3] Financial Performance and Cash Flow Concerns - Langyuan Co. has reported net losses from 2020 to 2023, with figures of -189 million yuan, -52.19 million yuan, -27.75 million yuan, and -53.63 million yuan [5] - In 2024, despite a revenue increase of 11.41% to 245 million yuan, the company still faced a net loss of 36.44 million yuan, primarily due to losses in the service sector [5][6] - The company's cash flow situation is troubling, with a net cash flow from operating activities of -34.70 million yuan in 2024, a significant decline of 494.05% compared to 2023 [6] Potential for Turnaround with New Shareholder - In April 2024, Dongfang Xingzhi became the controlling shareholder of Langyuan Co., which is linked to New Oriental Education, suggesting potential for capital and operational transformation [7] - Analysts believe that the involvement of the "Dongfang system" could provide opportunities for supply chain collaboration with Dongfang Zhenxuan, potentially leading to a turnaround for Langyuan Co. [7]

证券代码：300175 证券简称：ST 朗源 公告编号：2025-042 朗源股份有限公司 根据《公司法》、《公司章程》等有关规定，戚永楙先生的辞职不会导致公 司董事会成员低于法定最低人数，不会影响公司董事会正常运作，辞职报告自送 达公司董事会之日起生效。公司将按照有关规定，尽快完成董事及薪酬与考核委 员会委员的补选工作。 截至本公告披露之日，戚永楙先生未直接持有公司股份，通过新疆尚龙股权 投资管理有限公司间接持有公司 5,227.2 万股股份。戚永楙先生不存在应当履行 而未履行的承诺事项。 公司及董事会对戚永楙先生在担任董事期间为公司发展作出的贡献表示衷 心的感谢！ 特此公告。 朗源股份有限公司董事会 二〇二五年四月二十八日 关于公司董事辞职的公告 （本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。） 朗源股份有限公司（以下简称"公司"）董事会于近日收到董事戚永楙先生 提交的书面辞职报告。戚永楙先生因个人原因申请辞去公司第五届董事会董事、 副董事长及薪酬与考核委员会委员职务，其原定任期为 2024 年 5 月 20 日至 2027 年 5 月 19 日。辞去上 ...

2025年3月24日，公司披露了《关于公司及相关责任人收到<行政处罚事先告 知书>的公告》（公告编号：2025-003）及《关于公司股票交易将被实施其他风 险警示暨股票停复牌的提示性公告》（公告编号：2025-004）。 2025年4月25日，公司及相关责任人收到中国证监会山东监管局（以下简称 "山东证监局"）出具的《行政处罚决定书》（〔2025〕5号），现将具体情况 公告如下： 一、《行政处罚决定书》的具体内容 朗源股份有限公司 关于公司及相关责任人收到《行政处罚决定书》的公告 （本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。） 朗源股份有限公司（以下简称"公司"）于2024年9月13日收到中国证券监 督管理委员会（以下简称"中国证监会"）下发的《立案告知书》（编号：证监 立案字0042024015号），因涉嫌信息披露违法违规，根据《中华人民共和国证券 法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。 具体内容详见公司于2024年9月13日在巨潮资讯网（www.cninfo.com.cn）披露的 《关于收到中国证券监督管理委员会<立案告 ...

关于朗源股份有限公司 2024 年度营业收入 扣除事项的专项核查意见 中兴财光华审专字（2025）第 202118 号 目 录 关于朗源股份有限公司 2024 年度营业收入扣 除事项的专项核查意见 朗源股份有限公司 2024 年度营业收入扣除情 况表 关于朗源股份有限公司 2024 年度营业收入 扣除事项的专项核查意见 中兴财光华审专字(2025)第 202118 号 我们认为,后附的营业收入扣除情况表在所有重大方面按照《深圳证券 交易所创业板股票上市规则(2024年修订)》和《深圳证券交易所创业板上市 公司自律监管指南第1号——业务办理(2024年修订)》的规定编制,反映了朗 源股份公司2024年度营业收入扣除情况。 朗源股份有限公司全体股东: 我们接受委托,对朗源股份有限公司(以下简称"朗源股份")2024年 度财务报表进行审计,并出具了中兴财光华审会字(2025)第 202009 号审计 ' 报告。在此基础上,我们对朗源股份公司编制的《朗源股份有限公司 2024年 度营业收入扣除情况表》(以下简称"营业收入扣除情况表")进行了核查。 一、管理层的责任 朗 源 股 份 管 理 层 负 责 按 照 《深 圳 ...